Barclays
CLOV icon

Barclays’s Clover Health Investments CLOV Stock Holding History

Barclays’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.22M Buy
282,067
+214,409
+317% +$961K ﹤0.01% 2907
2026
Q2 		$355K Sell
67,658
-10,376
-13% -$35.2K ﹤0.01% 3393
2026
Q1 		$137K Sell
78,034
-559,245
-88% -$1.21M ﹤0.01% 3892
2025
Q4 		$1.5M Buy
637,279
+59,327
+10% +$162K ﹤0.01% 3139
2025
Q3 		$1.77M Sell
577,952
-222,722
-28% -$636K ﹤0.01% 2967
2025
Q2 		$2.23M Buy
800,674
+354,520
+79% +$1.17M ﹤0.01% 2760
2025
Q1 		$1.6M Sell
446,154
-15,538
-3% -$62.4K ﹤0.01% 2799
2024
Q4 		$1.45M Buy
461,692
+355,926
+337% +$1.27M ﹤0.01% 3122
2024
Q3 		$298K Buy
+105,766
New +$242K ﹤0.01% 4095
2024
Q2 		– Sell
-75,915
Closed -$60.3K – 4927
2024
Q1 		$60.3K Sell
75,915
-471,146
-86% -$429K ﹤0.01% 4576
2023
Q4 		$521K Buy
547,061
+481,828
+739% +$473K ﹤0.01% 3845
2023
Q3 		$70.5K Buy
65,233
+1,589
+2% +$1.89K ﹤0.01% 3720
2023
Q2 		$57.1K Sell
63,644
-172,612
-73% -$153K ﹤0.01% 3775
2023
Q1 		$200K Buy
236,256
+81,618
+53% +$89.3K ﹤0.01% 3795
2022
Q4 		$144K Buy
154,638
+87,349
+130% +$117K ﹤0.01% 4022
2022
Q3 		$115K Buy
67,289
+13,555
+25% +$35.5K ﹤0.01% 3481
2022
Q2 		$115K Buy
53,734
+51,694
+2,534% +$137K ﹤0.01% 3712
2022
Q1 		$7K Buy
+2,040
New +$5.92K ﹤0.01% 4652

Other funds holding CLOV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Kestra Private Wealth Services
Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return
OP Asset Management
OP Asset Management Helsinki $11.8B AUM 34.59% 1-Year Est. Return
Turtle Creek Wealth Advisors
Turtle Creek Wealth Advisors Dallas, Texas $1.98B AUM 28.66% 1-Year Est. Return

Barclays's CLOV Position: Q3 2026 in Review

Barclays increased its Clover Health Investments (CLOV) stake by 317% in Q3 2026, buying an estimated $961K and bringing the position to 282,067 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

Barclays first reported a position in CLOV in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.23M in Q2 2025. 93 funds tracked by Wall St. Rank hold CLOV as of Q3 2026.

  • Barclays held 282,067 shares of Clover Health Investments worth $1.22M as of Q3 2026.
  • Barclays bought 214,409 Clover Health Investments shares in Q3 2026, an estimated $961K.
  • Clover Health Investments made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #2907 holding.
  • Barclays first reported a position in Clover Health Investments in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Clover Health Investments position peaked at $2.23M in Q2 2025.
  • 93 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.